Dare Bioscience Inc is a biotechnology company focused on the development and commercialization of innovative therapeutic solutions, particularly in women's health care. The company is dedicated to addressing unmet medical needs by creating products aimed at enhancing reproductive health, contraception, and various gynecological conditions. With a portfolio of proprietary and partnered therapies, Dare Bioscience combines scientific expertise and cutting-edge technologies to deliver effective treatment options that improve the quality of life for women. Read More
Synergy CHC Corp. (NASDAQ: SNYR) is capturing national attention with the announcement of a strategic distribution partnership with McKesson Canada, a division of McKesson Corporation (NYSE: MCK) . The agreement gives FOCUSfactor® direct access to thousands of pharmacies and health-focused retailers across Canada, igniting the next phase of its aggressive North American expansion.
Bayer to present detailed Phase 3 OASIS 1 and 2 study results showing elinzanetant significantly reduces moderate to severe menopausal vasomotor symptoms compared to placebo.
